Caring Brands (CABR) Cost of Revenue (2024 - 2025)
Caring Brands (CABR) posted quarterly Cost of Revenue of $722.0 for Q4 2025, down 65.15% year-over-year from $2072.0 in Q4 2024, and up 147.26% quarter-over-quarter from $292.0 in Q3 2025.
Caring Brands (CABR) Cost of Revenue (2024 - 2025) Analysis & Trends
Caring Brands' Cost of Revenue history runs 2 years deep, the most recent figure standing at $722.0 for Q4 2025.
- In Q4 2025, Cost of Revenue fell 65.15% year-over-year to $722.0; the TTM figure through Dec 2025 stood at $3764.0 (changed N/A YoY), while the FY2025 annual figure was $1873.0, changed N/A from the prior year.
- Cost of Revenue for Q4 2025 stood at $722.0, up from $292.0 in the prior quarter.
- The five-year high for Cost of Revenue was $2072.0 in Q4 2024, with the low at $292.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Caring Brands | 11.78 Mn | 9.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 722.00 |
| Dec 31, 2025 | 722.00 |
| Sep 30, 2025 | 292.00 |
| Sep 30, 2025 | 292.00 |
| Mar 31, 2025 | 678.00 |
| Mar 31, 2025 | 678.00 |
| Dec 31, 2024 | 2,072.00 |
| Dec 31, 2024 | 2,072.00 |